Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bullorsky

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Survey of Ophthalmology|June 27, 2001
True, true and related?R Ebner, E DaCol, E Bullorsky
Bone Marrow Transplantation|May 1, 1988
Optimal time interval between myeloablative whole body irradiation and reconstitution with syngeneic bone marrow graftL Weiss, E Bullorsky, Y J Ashkenazi, et al.
Nephron|April 5, 2001
Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approachH Trimarchi, E Freixas, O Rabinovich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow TransplantS Pavlovsky, B Koziner, G Milone, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Survey of Ophthalmology|June 27, 2001
True, true and related?R Ebner, E DaCol, E Bullorsky
Bone Marrow Transplantation|May 1, 1988
Optimal time interval between myeloablative whole body irradiation and reconstitution with syngeneic bone marrow graftL Weiss, E Bullorsky, Y J Ashkenazi, et al.
Nephron|April 5, 2001
Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approachH Trimarchi, E Freixas, O Rabinovich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow TransplantS Pavlovsky, B Koziner, G Milone, et al.
Pageof 1